[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369590-105":59,"doc-detail-369590-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-relationship-between-polycystic-ovary-syndrome-and-gynecological-cancers-neurotransmitter-metabolism-changes-and-immune-regulation-review","The relationship between polycystic ovary syndrome and gynecological cancers: neurotransmitter metabolism changes and immune regulation - review","","Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by hirsutism, anovulation, and polycystic ovaries, and it is linked with metabolic disturbances affecting hormone and neurotransmitter pathways. Gynecological cancers show elevated incidence and PCOS may influence tumorigenesis and metastasis through chronic low-grade inflammation and immune dysregulation. This review synthesizes mechanistic evidence focusing on immune cell dysfunction, aberrant cytokine secretion, impaired immune metabolism, and neurotransmitter-related changes, and it outlines potential therapeutic strategies to mitigate cancer risk while identifying gaps for further research.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-relationship-between-polycystic-ovary-syndrome-and-gynecological-cancers-neurotransmitter-metabolism-changes-and-immune-regulation-review/369590/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-relationship-between-polycystic-ovary-syndrome-and-gynecological-cancers-neurotransmitter-metabolism-changes-and-immune-regulation-review/369590.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What core conditions define polycystic ovary syndrome in this review?","Question",{"text":113,"@type":114},"PCOS is described as an endocrine disorder characterized by hirsutism, anovulation, and polycystic ovaries, and it is diagnosed using the Rotterdam criteria including oligo/anovulation, hyperandrogenism, and ovarian morphology.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the review connect PCOS with gynecological cancers?",{"text":118,"@type":114},"The review links PCOS to cancer development through hormonal alterations, chronic low-grade inflammation, dysregulated cytokine secretion, and immune dysregulation that impairs tumor immune clearance and supports metastasis.",{"name":120,"@type":111,"acceptedAnswer":121},"What biological pathways does the review highlight as potential therapeutic targets?",{"text":122,"@type":114},"It emphasizes neurotransmitter metabolism changes and immune regulation, and discusses potential strategies such as hormonal interventions, insulin sensitizers, and lifestyle modifications to modulate these pathways and reduce cancer risk.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369590,1790276889,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","TYPE Review  \nPUBLISHED 04 June 2025  \nDOI 10.3389/fimmu.2025.1578470  \nOPEN ACCESS  \nEDITED BY  \nQihang Yuan,  \nDalian Medical University, China  \nREVIEWED BY  \nHao Chi,  \nSouthwest Medical University, China Xi Yong,  \nNingbo Medical Centre Lihuili Hospital, China  \n*CORRESPONDENCE  \nMin Chen  \n [mchen@must.edu. mo](mchen@must.edu. mo)[ ](mchen@must.edu. mo)Jinxia Ni  \n [nijinxia118@126.com](nijinxia118@126.com)  \n†These authors share ﬁrst authorship  \nRECEIVED 17 February 2025  \nACCEPTED 22 April 2025  \nPUBLISHED 04 June 2025  \nCITATION  \nWu D, Zhang Y, Wu C, An B, Wang X, Ni J and Chen M (2025) The relationship between polycystic ovary syndrome and gynecological cancers: neurotransmitter metabolism changes and immune regulation.  \nFront. Immunol. 16:1578470 .  \ndoi: 10.3389/fimmu.2025.1578470  \nCOPYRIGHT  \n© 2025 Wu, Zhang, Wu, An, Wang, Ni and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe relationship between polycystic ovary syndrome and gynecological cancers:  \nneurotransmitter metabolism changes and immune regulation  \nDongning Wu1,2,3†, Yue Zhang 4†, Congying Wu 2, Bo An 5,6, Xin Wang 7, Jinxia Ni 2* and Min Chen 1*  \n1 Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China, 2 Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China, 3Xidan Clinic of Guang ’anmen Hospital, Chinese Academy of Chinese Medicine Science, Beijing, China, 4Guang ’anmen Hospital, Chinese Academy of Chinese Medicine Science, Beijing, China, 5The First Afﬁliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China, 6Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, China, 7 Data Center of Chinese Medical, China Academy of Chinese Medical Sciences, Beijing, China  \nPolycystic ovary syndrome (PCOS) is a common endocrine disorder affecting approximately 10% of middle-aged women worldwide. It is characterized by hirsutism, anovulation, and polycystic ovaries. Various factors, including environmental toxins, inﬂammation, oxidative stress, and insulin resistance, contribute to the progression of this condition. PCOS is also associated with metabolic disturbances, such as abnormal hormone and neurotransmitter metabolism, leading to obesity, hyperandrogenemia, and type 2 diabetes. Among female cancers, breast cancer, endometrial cancer, and ovarian cancer have high incidence rates and pose signiﬁcant threats to women ’s health. Studies suggest a potential link between PCOS and these gynecological cancers. Consequently, hormonal alterations in PCOS patients may inﬂuence tumorigenesis and metastasis. Moreover, PCOS is characterized by chronic low-grade inﬂammation, including dysregulated pro-inﬂammatory cytokine secretion, increased immune cell proliferation, and endothelial dysfunction. These factors contribute to cancer development, primarily through impaired immune metabolism, preventing effective tumor cell clearance and facilitating metastasis. This review synthesizes current knowledge on the mechanistic links between PCOS and gynecological cancers, focusing on the roles of immune cell dysfunction, aberrant cytokine secretion, and neurotransmitter metabolism. Therapeutic strategies, including hormonal interventions, insulin sensitizers, and lifestyle modiﬁcations, may mitigate cancer risk by modulating these pathways. This review highlights critical gaps in understanding PCOS-related oncogenesis and advocates for further research to elucidate molecular mechanisms and optimize clinical managem","cbCaihe8ParWm94m","https://ap.wps.com/l/cbCaihe8ParWm94m","pdf",1253660,11,"English","# Introduction\n## PCOS overview and diagnostic criteria\n## Inflammation, immune dysfunction, and cancer risk\n# Immune mechanisms in PCOS-related cancer development\n## Macrophage polarization and cytokine cycles\n## Dendritic cells, NK cells, and T lymphocytes","[{\"question\":\"What core conditions define polycystic ovary syndrome in this review?\",\"answer\":\"PCOS is described as an endocrine disorder characterized by hirsutism, anovulation, and polycystic ovaries, and it is diagnosed using the Rotterdam criteria including oligo/anovulation, hyperandrogenism, and ovarian morphology.\"},{\"question\":\"How does the review connect PCOS with gynecological cancers?\",\"answer\":\"The review links PCOS to cancer development through hormonal alterations, chronic low-grade inflammation, dysregulated cytokine secretion, and immune dysregulation that impairs tumor immune clearance and supports metastasis.\"},{\"question\":\"What biological pathways does the review highlight as potential therapeutic targets?\",\"answer\":\"It emphasizes neurotransmitter metabolism changes and immune regulation, and discusses potential strategies such as hormonal interventions, insulin sensitizers, and lifestyle modifications to modulate these pathways and reduce cancer risk.\"}]","The relationship between polycystic ovary syndrome and gynecological cancers: neurotransmitter metabolism changes and immune regulation - review | PDF",1790183581,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70edc8ae94be4936eaf6cf9599fa2987.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b42a49eac9f54a6bc589253e74b94801.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6d124068eb72761914b05363335d921.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92a50d245843973278de4b30e01fc9f9.webp",980,1385]